Skip to main content
logo
Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
27.33
+0.41 (1.52%)
At close: Aug 3, 2026, 4:00 PM EDT
28.10
+0.77 (2.82%)
Pre-market: Aug 4, 2026, 4:00 AM EDT

Maze Therapeutics Revenue

Maze Therapeutics had revenue of $20.00M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $20.00M, down -88.06% year-over-year.

Revenue (ttm)
$20.00M
Revenue Growth
-88.06%
P/S Ratio
75.63
Revenue / Employee
$141,844
Employees
141
Market Cap
1.51B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024167.50M--
Dec 31, 2023---
Dec 31, 2022---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

MAZE News

More News